Summary:

By 2028, India's healthcare sector is expected to be worth US$320 billion. The pharmaceutical sector aims to generate US$130 billion by 2030, while biotechnology aspires to reach US$300 billion by the same year. Over the past year, the industries have seen tremendous growth, driven by global expansion, mergers and acquisitions, and investment in talent. Companies leverage India's skilled workforce to drive innovation and align employee goals with technological advancements, such as artificial intelligence (AI).

The report highlights the increasing focus on employee development, noting that 85% of employees in India's Best Workplaces believe their companies excel, with 89% satisfaction at top-ranked firms. With healthcare AI investments expected to reach US$1.6 billion by 2025, India is fostering innovation. Challenges include improving efficiency with AI, inclusive hiring, and leadership development. The pharmaceutical industry focuses on skill development, while healthcare adopts technology and flexible models, and biotech companies emphasize training and upskilling.

Source: IBEF

Disclaimer: The information on this website comes from the India Brand Equity Foundation (IBEF), a reliable source for thorough insights into numerous areas of the Indian economy. While we aim to offer accurate and up-to-date information, the views, opinions, and analyses stated herein are solely those of the authors and contributors and do not necessarily represent IBEF's official stance or position. Readers should check information from credible sources and use their own discretion when relying on content provided on this site. We assume no responsibility or liability for the supplied content, including its accuracy, completeness, and usefulness.